Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Biol Chem ; 290(47): 28056-28069, 2015 Nov 20.
Artículo en Inglés | MEDLINE | ID: mdl-26359495

RESUMEN

SNAREs constitute the core machinery of intracellular membrane fusion, but vesicular SNAREs localize to specific compartments via largely unknown mechanisms. Here, we identified an interaction between VAMP7 and SNAP-47 using a proteomics approach. We found that SNAP-47 mainly localized to cytoplasm, the endoplasmic reticulum (ER), and ERGIC and could also shuttle between the cytoplasm and the nucleus. SNAP-47 preferentially interacted with the trans-Golgi network VAMP4 and post-Golgi VAMP7 and -8. SNAP-47 also interacted with ER and Golgi syntaxin 5 and with syntaxin 1 in the absence of Munc18a, when syntaxin 1 is retained in the ER. A C-terminally truncated SNAP-47 was impaired in interaction with VAMPs and affected their subcellular distribution. SNAP-47 silencing further shifted the subcellular localization of VAMP4 from the Golgi apparatus to the ER. WT and mutant SNAP-47 overexpression impaired VAMP7 exocytic activity. We conclude that SNAP-47 plays a role in the proper localization and function of a subset of VAMPs likely via regulation of their transport through the early secretory pathway.


Asunto(s)
Proteínas Q-SNARE/fisiología , Proteínas R-SNARE/metabolismo , Animales , Perros , Células de Riñón Canino Madin Darby , Transporte de Proteínas , Fracciones Subcelulares/metabolismo
2.
Peptides ; 25(3): 339-57, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15134859

RESUMEN

Several aspects of our 25 year adventure in the field of tachykinins will be successively described. They concern: substance P (SP) synthesis and release in the basal ganglia, the identification and pharmacological characterization of central tachykinin NK(1), NK(2) and NK(3) binding sites and their topographical distribution, the description of some new biological tests for corresponding receptors, the identification of tachykinin NK(1) receptor subtypes or conformers sensitive to all endogenous tachykinins (substance P, neurokinin A (NKA), neurokinin B (NKB), neuropeptide gamma (NP gamma) and neuropeptide K (NPK)) and finally, the functional involvement of these receptors and their subtypes in tachykinin-induced regulations of dopamine and acetylcholine release in the striatum.


Asunto(s)
Taquicininas/fisiología , Animales , Sitios de Unión , Cuerpo Estriado/metabolismo , Humanos , Corteza Prefrontal/diagnóstico por imagen , Corteza Prefrontal/metabolismo , Radiografía , Receptores de Taquicininas/análisis , Receptores de Taquicininas/metabolismo , Sustancia P/metabolismo , Sustancia Negra/metabolismo
3.
J Neurochem ; 87(2): 487-96, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-14511126

RESUMEN

Using an in vitro microsuperfusion procedure, the NMDA-evoked release of [3H]ACh was studied after suppression of dopamine (DA) transmission (alpha-methyl-p-tyrosine) in striatal compartments of the rat. The effects of tachykinin neurokinin 1 (NK1) receptor antagonists and the ability of appropriate agonists to counteract the antagonist responses were investigated to determine whether tachykinin NK1 classic, septide-sensitive and/or new NK1-sensitive receptors mediate these regulations. The NK1 antagonists, SR140333, SSR240600, GR205171 but not GR82334 and RP67580 (0.1 and 1 microM) markedly reduced the NMDA (1 mm + D-serine 10 microM)-evoked release of [3H]ACh only in the matrix. These responses unchanged by coapplication with NMDA of NK2 or NK3 agonists, [Lys5,MeLeu9,Nle10]NKA(4-10) or senktide, respectively, were completely counteracted by the selective NK1 agonist, [Pro9]substance P but also by neurokinin A and neuropeptide K (1 nM each). According to the rank order of potency of agonists for counteracting the antagonist responses ([Pro9]substance P, 0.013 nM > neurokinin A, 0.15 nM >> substance P(6-11) 7.7 nM = septide 8.7 nM), the new NK1-sensitive receptors mediate the facilitation by endogenous tachykinins of the NMDA-evoked release of ACh in the matrix, after suppression of DA transmission. Solely the NK1 antagonists having a high affinity for these receptors could be used as indirect anti-cholinergic agents.


Asunto(s)
Acetilcolina/metabolismo , Cuerpo Estriado/metabolismo , N-Metilaspartato/farmacología , Receptores de Neuroquinina-1/metabolismo , Sustancia P/análogos & derivados , Taquicininas/metabolismo , Animales , Cuerpo Estriado/efectos de los fármacos , Dopamina/metabolismo , Técnicas In Vitro , Masculino , Morfolinas/farmacología , Antagonistas del Receptor de Neuroquinina-1 , Fragmentos de Péptidos/farmacología , Perfusión , Piperidinas/farmacología , Quinuclidinas/farmacología , Ratas , Ratas Sprague-Dawley , Receptores de Neuroquinina-1/agonistas , Receptores de Neuroquinina-2/agonistas , Receptores de Neuroquinina-3/agonistas , Sustancia P/farmacología , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/fisiología , Tetrazoles/farmacología , alfa-Metiltirosina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...